Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 431-870-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
A guinea pig maximisation study was carried out to determine the skin sensitisation potential of the substance BMS 217947-01. The substance (50% w/v) induced an allergic skin reaction to all 9 animals that survived the 21 -day observation period (one was killed for humane reasons). It is therefore considered to be an "extreme sensitiser" and is classified as Skin Sensitiser, Category 1B, according to the CLP Regulation.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16th Nov 1998 - 25th Dec 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: done under GLP and OECD method
- Qualifier:
- according to guideline
- Guideline:
- other: Directive 96/54/EC, Method B6;OECD Guideline No.406
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was conducted prior to amendments to Annex VII
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- albino
- Concentration / amount:
- Concentration of test material and vehicle used at induction:
Intradermal induction: 10% w/v in arachis oil BP
Topical application: 50% w/w in arachis oil BP
Concentration of test material and vehicle used for each challenge:
50% and 25% w/w in arachis oil BP - Concentration / amount:
- Concentration of test material and vehicle used at induction:
Intradermal induction: 10% w/v in arachis oil BP
Topical application: 50% w/w in arachis oil BP
Concentration of test material and vehicle used for each challenge:
50% and 25% w/w in arachis oil BP - No. of animals per dose:
- Number of animals in test group: 10
Number of animals in negative control group: 5 - Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50 %. No with. + reactions: 9.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25 %. No with. + reactions: 9.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50 %
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50 %. No with. + reactions: 9.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 %
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 6.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The test substance requires labelling with the risk phrase R43 "May cause sensitisation by skin contact". This corresponds to Category 1 Skin Sensitisation according to CLP Regulation. This substance gave a response in 100% of animals at both doses used. It therefore appears to be an extreme sensitizer.
- Executive summary:
A guinea pig maximisation study was carried out to determine the skin sensitisation potential of the substance BMS 217947-01. The substance (50% w/v) induced an allergic skin reaction to all 9 animals that survived the 21 -day observation period (one was killed for humane reasons). It is therefore considered to be an "extreme sensitiser" and is classified as Skin Sensitiser, Category 1B, according to the CLP Regulation.
Reference
Maximum concentration not causing irritating effects in preliminary test: 5 %
Signs of irritation during induction:
Very slight to well-defined erythema with or without very
slight to slight oedema was noted at the topical induction
sites of all test group animals at the 1-hour observation.
Well-defined erythema with very slight oedema persisted at
the topical induction sites of two test group animals at the
24-hour observation. Bleeding from the intradermal injection
sites was noted in eight test group animals with subsequent
small superficial scattered scabs, hardened dark
brown/black-coloured scabs or hardened light brown-coloured
scabs. These adverse reactions precluded accurate assessment
of the erythema and oedema at the other topical induction
sites at the 24-hour observation.
No erythema or oedema was noted at the topical induction
sites of control group animals at the 1 and 24-hour
observations. Bleeding from the intradermal injection sites
was noted in three control group animals at the 1-hour
observation.
Evidence of sensitisation of each challenge concentration:
The test material produced a 100% (9/9) sensitisation rate.
Other observations:
One test animal was killed for humane reasons on Day 21.
After the topical challenge with 50% (w/v)
substance,positive skin responses (erythema grade 1 or 2)
with or without very slight to slight oedema (grade 1 or 2)
was noted at the challenge sites of all test groups animals
at the 24 and 48 hour observations.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Justification for classification or non-classification
The substance (50% w/v) induced an allergic skin reaction to all 9 animals that survived the 21 -day observation period (one was killed for humane reasons). It is therefore considered to be an "extreme sensitiser" and is classified as Skin Sensitiser, Category 1B, according to the CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
